PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials

2013-10-24
(Press-News.org) Contact information: Steve Graff
stephen.graff@uphs.upenn.edu
215-349-5653
University of Pennsylvania School of Medicine
Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials SYDNEY, AUSTRALIA— Clinical trials are key to finding new cancer treatments, but with patient participation hovering around 5 percent, new strategies are needed to boost enrollment, particularly to study the rare cancers that have so few cases. One such strategy comes from a new abstract being presented October 28 at the 15th World Conference on Lung Cancer from researchers at Perelman School of Medicine at the University of Pennsylvania studying mesothelioma.

Results from a willingness to participate study, led by Charles B. Simone, MD, chief of Thoracic Oncology and assistant professor of Radiation Oncology at Penn's Abramson Cancer Center, found that focusing on particular factors—including hope for positive outcomes, randomization and altruism— and increasing the time spent with patients increased their likelihood of participating in a clinical trial for malignant pleural mesothelioma (MPM), a rare cancer often diagnosed in people who have been exposed to high levels of asbestos.

"Spending time with patients to thoroughly discuss the details, logistics, risks and benefits of enrollment can allow patients to have a better understanding of the proposed study, empower patients, and make them more likely to consider enrollment," said Dr. Simone. "Furthermore, identifying factors that may serve as obstacles to enrollment of a proposed study is critical and can help to tailor the discussion that researchers have with patients to address, substantiate, or alleviate their potential concerns."

The team, including Joseph S. Friedberg, MD, chief of the division of Thoracic Surgery and co-director of the Penn Mesothelioma and Pleural Disease Program, demonstrated unusually good results treating MPM with radical pleurectomy (RP), intraoperative photodynamic therapy (PDT), and chemotherapy. To establish if PDT is contributing to the results, a randomized trial of RP with and without PDT is needed. However, finding patients to enroll in such a trial is difficult.

To see if they could conduct the trial, the researchers conducted the willingness to participate study.

Patients with MPM who were candidates for RP plus PDT were enrolled. A total of 25 patients participated in structured interviews, reviewed a written description of a hypothetical randomized controlled trial comparing RP to RP plus PDT, answered open-ended and focused questions regarding their motivations for and concerns about enrollment, and completed a written questionnaire. Willingness to participate was assessed using a 6-point scale: 1=definitely not, 6=definitely.

Once factors were identified in eight patients, researchers trained physicians to spend more time talking about these factors with subsequent patients, and the length of time physician spent discussing the trial increased from 3 minutes to 9 minutes. Such factors included hope for positive outcomes, explaining the randomization process, physician's opinion, and altruism towards other patients. Focusing on such factors in the latter group resulted in a more willingness to participate: 71 percent of subsequent patients stated they would "definitely" or "probably" participate, as opposed to only 25 percent in the first group.

"Performing a willingness to participate study should be considered before a planned prospective clinical trial, especially for orphan diseases and rare conditions that are typically associated with poor clinical trial accrual," said Dr. Simone.

INFORMATION:

This study is one of 13 Penn Medicine studies and talks being presented at the International Association for the Study of Lung Cancer's 15th World Conference on Lung Cancer.

Co-authors of the study from Penn Medicine include Anand Shah, Melissa J. Culligan, Daniel Sterman, Evan Alley, Keith A. Cengel, and Stephen M. Hahn, and James P. Stevenson from the Cleveland Clinic.

END



ELSE PRESS RELEASES FROM THIS DATE:

USC researcher learns how to break a sweat

2013-10-24
USC researcher learns how to break a sweat Without sweat, we would overheat and die. In a recent paper in the journal PLOS ONE, USC faculty member Krzysztof Kobielak and a team of researchers explored the ultimate origin of this sticky, stinky ...

New device stores electricity on silicon chips

2013-10-23
New device stores electricity on silicon chips Solar cells that produce electricity 24/7, not just when the sun is shining. Mobile phones with built-in power cells that recharge in seconds and work for weeks between charges. These are just two ...

Mount Sinai finds value and limitations of patient assistance programs for women with breast cancer

2013-10-23
Mount Sinai finds value and limitations of patient assistance programs for women with breast cancer Nearly 80 percent of women who contacted a patient assistance program had some or all of their needs met, compared with ...

Advanced light source provides a new look at vanadium dioxide

2013-10-23
Advanced light source provides a new look at vanadium dioxide Graphene may command the lion's share of attention but it is not the only material generating buzz in the electronics world. Vanadium dioxide is one of the few known materials that acts ...

Gravitational waves 'know' how black holes grow

2013-10-23
Gravitational waves 'know' how black holes grow Supermassive black holes: every large galaxy's got one. But how did they grow so big? A paper in the journal Science pits the front-running ideas about the growth of supermassive black holes against observational data — a limit ...

There's gold in them thar trees

2013-10-23
There's gold in them thar trees Eucalyptus trees - or gum trees as they are know - are drawing up gold particles from the earth via their root system and depositing it their leaves and branches. Scientists from CSIRO made the discovery and have published their findings ...

The hitchhiker antigen: Cause for concern?

2013-10-23
The hitchhiker antigen: Cause for concern? Since antibodies first attained prominence as research reagents in modern biological science labs, researchers have been perplexed as to why one production lot can differ significantly from the next, ...

How are Open Access and MOOCS disrupting the academic community in different ways?

2013-10-23
How are Open Access and MOOCS disrupting the academic community in different ways? New article in SAGE Open compares and contrasts the disruptive tensions of open-access publishing with MOOCs Los Angeles, CA (October 23, 2013) Supporters of open academic content ...

New eye treatment effective in laboratory tests

2013-10-23
New eye treatment effective in laboratory tests Promising new approach may lead to treatments for common eye diseases like neovascular macular degeneration and diabetic retinopathy LA JOLLA, CA – October 23, 2013 – A promising technique for treating human eye disease ...

Changes in epigenetic DNA functions reveal how diabetes predisposes individuals to Alzheimer's

2013-10-23
Changes in epigenetic DNA functions reveal how diabetes predisposes individuals to Alzheimer's Mount Sinai researchers hope to exploit findings to develop novel preventive and treatment strategies for Alzheimer's disease New ...

LAST 30 PRESS RELEASES:

Cobalt single atom-phosphate functionalized reduced graphene oxide/perylenetetracarboxylic acid nanosheet heterojunctions for efficiently photocatalytic H2O2 production

World-first study shows Australian marsupials contaminated with harmful ‘forever chemicals’

Unlocking the brain’s hidden drainage system

Enhancing smoking cessation treatment for people living with HIV

Research spotlight: Mapping how gut neurons respond to bacteria, parasites and food allergy

Gordon and Betty Moore Foundation Experimental Physics Investigators awards to UCSB experimentalists opens the door to new insights and innovations

Meerkats get health benefit from mob membership

COVID-19 during pregnancy linked to higher risk of neurodevelopmental disorders in children

How a chorus of synchronized frequencies helps you digest your food

UAlbany researcher partners on $1.2 million NSF grant to explore tropical monsoon rainfall patterns

Checkup time for Fido? Wait might be longer in the country

Genetic variation impact scores: A new tool for earlier heart disease detection

The Lundquist Institute awarded $9 million to launch Community Center of Excellence for Regenerative Medicine

'Really bizarre and exciting': The quantum oscillations are coming from inside

Is AI becoming selfish?

New molten salt method gives old lithium batteries a second life

Leg, foot amputations increased 65% in Illinois hospitals between 2016-2023

Moffitt studies uncover complementary strategies to overcome resistance to KRAS G12Cinhibitors in lung cancer

National summit of experts charts unprecedented roadmap to reduce harms from firearms in new ways

Global environmental DNA (eDNA) surveys significantly expand known geographic and ecological niche ranges of marine fish, highlighting current biases in conservation and ecological modeling

Hundreds of animal studies on brain damage after stroke flagged for problematic images

Prize winner’s research reveals how complex neural circuits are correctly wired during brain development

Supershear rupture sustained in thick fault zone during 2025 Mandalay earthquake, study in research package shows

Study reveals how brain cell networks stabilize memory formation

CTE: More than just head trauma, suggests new study

New psychology study suggests chimpanzees might be rational thinkers

Study links genetic variants to higher 'bad' cholesterol and heart attack risk

Myanmar fault had ideal geometry to produce 2025 supershear earthquake

Breakthrough in BRCA2 research: a novel mechanism behind chemoresistance discovered

New funding for health economics research on substance use disorder treatments

[Press-News.org] Penn docs find successful strategy to expand patient participation in hard-to-enroll clinical trials